Huang et al., 2015 - Google Patents
Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation‐wide cohort studyHuang et al., 2015
- Document ID
- 2166126922530996894
- Author
- Huang Y
- Wang T
- Yang S
- Lin S
- Fu S
- Hu J
- Liu C
- Kao J
- Chen D
- Publication year
- Publication venue
- Alimentary pharmacology & therapeutics
External Links
Snippet
Background The impact of diabetes for hepatocellular carcinoma (HCC) development in chronic hepatitis C (CHC) patients remains controversial. Aim To investigate the risk of HCC in CHC patients who develop new onset diabetes. Methods We conducted a nation‐wide …
- 206010012601 Diabetes mellitus 0 title abstract description 125
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/30—Information retrieval; Database structures therefor; File system structures therefor
- G06F17/30286—Information retrieval; Database structures therefor; File system structures therefor in structured data stores
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/20—Handling natural language data
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/01—Social networking
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bartlett et al. | The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: impact of direct acting antivirals | |
| Fu et al. | Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study | |
| Huang et al. | Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation‐wide cohort study | |
| Singal et al. | Alcohol‐associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics | |
| Pol et al. | The negative impact of HBV/HCV coinfection on cirrhosis and its consequences | |
| Linas et al. | The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection | |
| Hsu et al. | Interferon‐based therapy reduces risk of stroke in chronic hepatitis C patients: a population‐based cohort study in Taiwan | |
| Huang et al. | Statins reduce the risk of cirrhosis and its decompensation in chronic hepatitis B patients: a nationwide cohort study | |
| Aleman et al. | A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C–associated liver cirrhosis | |
| Deleuran et al. | Cirrhosis and mortality risks of biopsy‐verified alcoholic pure steatosis and steatohepatitis: a nationwide registry‐based study | |
| Gidding et al. | Predictors of deferral of treatment for hepatitis C infection in Australian clinics | |
| Stepanova et al. | Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity | |
| Janjua et al. | The impact of SVR from direct‐acting antiviral‐and interferon‐based treatments for HCV on hepatocellular carcinoma risk | |
| Samji et al. | Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development | |
| Wijarnpreecha et al. | Higher mortality among lean patients with non‐alcoholic fatty liver disease despite fewer metabolic comorbidities | |
| Lin et al. | Inverse association between cancer risks and age in schizophrenic patients: A 12‐year nationwide cohort study | |
| Sahakyan et al. | Impact of direct‐acting antiviral regimens on mortality and morbidity outcomes in patients with chronic hepatitis C: systematic review and meta‐analysis | |
| Huang et al. | Diabetes, hepatocellular carcinoma, and mortality in hepatitis C‐infected patients: a population‐based cohort study | |
| Chiang et al. | Serum adiponectin levels are associated with hepatitis B viral load in overweight to obese hepatitis B virus carriers | |
| Le et al. | Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: results from modelling and global reporting | |
| Trimble et al. | Mortality associated with alcohol‐related liver disease | |
| Kim et al. | Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients | |
| Fan et al. | Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy | |
| Almario et al. | Examining hepatitis C virus testing practices in primary care clinics | |
| Alavi et al. | Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study |